Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2017 2
2018 3
2019 6
2020 6
2021 6
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Biologic Therapies and Autoimmune Phenomena.
Drosos AA, Pelechas E, Kaltsonoudis E, Markatseli TE, Voulgari PV. Drosos AA, et al. Among authors: kaltsonoudis e. Mediterr J Rheumatol. 2021 Jun 30;32(2):96-103. doi: 10.31138/mjr.32.2.96. eCollection 2021 Jun. Mediterr J Rheumatol. 2021. PMID: 34447904 Free PMC article. Review.
Neuroinflammatory events after anti-TNFα therapy.
Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA. Kaltsonoudis E, et al. Ann Rheum Dis. 2022 May;81(5):e73. doi: 10.1136/annrheumdis-2020-217723. Epub 2020 May 20. Ann Rheum Dis. 2022. PMID: 32434825 No abstract available.
Clinical features and diagnostic tools in idiopathic inflammatory myopathies.
Tsamis KI, Boutsoras C, Kaltsonoudis E, Pelechas E, Nikas IP, Simos YV, Voulgari PV, Sarmas I. Tsamis KI, et al. Among authors: kaltsonoudis e. Crit Rev Clin Lab Sci. 2022 Jun;59(4):219-240. doi: 10.1080/10408363.2021.2000584. Epub 2021 Nov 12. Crit Rev Clin Lab Sci. 2022. PMID: 34767470 Review.
State of the Art Review on the Treatment of Psoriatic Disease.
Pelechas E, Kaltsonoudis E, Migkos MP, Koletsos N, Karagianni PG, Drosos AA, Voulgari PV. Pelechas E, et al. Among authors: kaltsonoudis e. Mediterr J Rheumatol. 2024 Jan 31;35(1):66-72. doi: 10.31138/mjr.040123.sot. eCollection 2024 Mar. Mediterr J Rheumatol. 2024. PMID: 38736956 Free PMC article. Review.
Dermatomyositis sine myositis - Case presentation.
Kaltsonoudis E, Pelechas E, Drosos AA. Kaltsonoudis E, et al. Mediterr J Rheumatol. 2017 Mar 28;28(1):57-58. doi: 10.31138/mjr.28.1.57. eCollection 2017 Mar. Mediterr J Rheumatol. 2017. PMID: 32185256 Free PMC article.
Reply to the Editor.
Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA. Kaltsonoudis E, et al. Semin Arthritis Rheum. 2020 Apr;50(2):e7. doi: 10.1016/j.semarthrit.2019.07.005. Epub 2019 Aug 1. Semin Arthritis Rheum. 2020. PMID: 31466838 No abstract available.
Adalimumab in the treatment of rheumatoid arthritis.
Voulgari PV, Kaltsonoudis E, Papagoras C, Drosos AA. Voulgari PV, et al. Among authors: kaltsonoudis e. Expert Opin Biol Ther. 2012 Dec;12(12):1679-86. doi: 10.1517/14712598.2012.721771. Epub 2012 Sep 6. Expert Opin Biol Ther. 2012. PMID: 22954150
Biosimilars and retention rates in patients with ankylosing spondylitis.
Pelechas E, Kaltsonoudis E, Voulgari PV, Drosos AA. Pelechas E, et al. Among authors: kaltsonoudis e. Clin Exp Rheumatol. 2021 Mar-Apr;39(2):440. doi: 10.55563/clinexprheumatol/4cualr. Epub 2020 Oct 18. Clin Exp Rheumatol. 2021. PMID: 33124580 Free article. No abstract available.
28 results